Moreover, the deubiquitinating enzyme ubiquitin-specific peptidase 15 expression level was significantly downregulated in CML patients by blocking JAK/STAT5 pathway and involved in imatinib resistance (27). The gene discussed is USP15; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.